Cardiol Therapeutics begins Phase II study of CardiolRx for treatment of recurrent pericarditis

News Direct

Dec 16, 2022

–News Direct–

Contact Details

Proactive Canada

Proactive Canada

+1 604-688-8158

na-editorial@proactiveinvestors.com

View original content to download multimedia: https://newsdirect.com/news/cardiol-therapeutics-begins-phase-ii-study-of-cardiolrx-for-treatment-of-recurrent-pericarditis-119915921

YOU MAY ALSO LIKE

Intus Care Announces Launch of CareHub, an…

--News Direct--Contact DetailsProactive CanadaProactive Canada+1 604-688-8158na-editorial@proactiveinvestors.comView original content to download multimedia: https://newsdirect.com/news/cardiol-therapeutics-begins-phase-ii-study-of-cardiolrx-for-treatment-of-recurrent-pericarditis-119915921

read more

PathAI Announces Collaboration with the Crohn’s &…

--News Direct--Contact DetailsProactive CanadaProactive Canada+1 604-688-8158na-editorial@proactiveinvestors.comView original content to download multimedia: https://newsdirect.com/news/cardiol-therapeutics-begins-phase-ii-study-of-cardiolrx-for-treatment-of-recurrent-pericarditis-119915921

read more

Direxion Launches Netflix and Taiwan Semiconductor Manufacturing…

--News Direct--Contact DetailsProactive CanadaProactive Canada+1 604-688-8158na-editorial@proactiveinvestors.comView original content to download multimedia: https://newsdirect.com/news/cardiol-therapeutics-begins-phase-ii-study-of-cardiolrx-for-treatment-of-recurrent-pericarditis-119915921

read more